PREVIOUS QUESTION:

 

NEXT QUESTION:

 

When is autologous stem cell transplantation done for Hodgkin's lymphoma?

ANSWER

Patients with Hodgkin's lymphoma that is resistant to treatment or returns after initial treatment may need autologous stem cell transplantation. In this procedure, higher doses of chemotherapy or total body irradiation are applied in an effort to destroy lymphoma cells that have survived standard therapy. The higher doses of therapy are likely to destroy normal blood and bone marrow cells. Therefore, normal bone marrow stem cells are taken from the patient’s bloodstream before he or she undergoes chemotherapy or radiation. The stem cells are returned to the body intravenously after the treatment.

SOURCES: 

News release, FDA. 

National Cancer Institute. 

National Lymphoma Network.

American Cancer Society.

Reviewed by Laura J. Martin on July 18, 2017

SOURCES: 

News release, FDA. 

National Cancer Institute. 

National Lymphoma Network.

American Cancer Society.

Reviewed by Laura J. Martin on July 18, 2017

NEXT QUESTION:

How can brentuximab vedotin (Adcetris) help treat Hodgkin's lymphoma?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: